Calamos Wealth Management LLC acquired a new position in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 9,933 shares of the medical research company’s stock, valued at approximately $638,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of A. Dimensional Fund Advisors LP grew its holdings in Agilent Technologies by 1.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,156,150 shares of the medical research company’s stock valued at $61,128,000 after buying an additional 17,169 shares in the last quarter. BlueCrest Capital Management Ltd purchased a new position in shares of Agilent Technologies in the 1st quarter worth approximately $253,000. HighTower Advisors LLC boosted its holdings in shares of Agilent Technologies by 37.4% in the 1st quarter. HighTower Advisors LLC now owns 12,875 shares of the medical research company’s stock worth $678,000 after purchasing an additional 3,504 shares during the period. FNY Partners Fund LP purchased a new position in shares of Agilent Technologies in the 1st quarter worth approximately $264,000. Finally, Point72 Asset Management L.P. boosted its holdings in shares of Agilent Technologies by 169.0% in the 1st quarter. Point72 Asset Management L.P. now owns 996,237 shares of the medical research company’s stock worth $52,671,000 after purchasing an additional 625,937 shares during the period.
In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the transaction, the chief financial officer now owns 164,202 shares of the company’s stock, valued at $10,837,332. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $63.63, for a total value of $286,335.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 165,720 shares of company stock worth $10,488,739.
A number of equities research analysts recently issued reports on A shares. Robert W. Baird reissued a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Friday, October 20th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a research report on Tuesday, October 10th. Deutsche Bank AG set a $68.00 target price on Agilent Technologies and gave the company a “buy” rating in a research report on Wednesday, August 16th. Barclays PLC reaffirmed a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a research report on Wednesday, July 19th. Finally, BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $66.70.
Agilent Technologies, Inc. (NYSE:A) traded up $0.32 during mid-day trading on Tuesday, hitting $67.13. The stock had a trading volume of 1,536,300 shares, compared to its average volume of 1,820,754. The stock has a market capitalization of $21,720.00, a price-to-earnings ratio of 29.17, a PEG ratio of 2.62 and a beta of 1.28. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $68.67. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period last year, the business posted $0.49 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. equities research analysts forecast that Agilent Technologies, Inc. will post 2.32 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd were given a dividend of $0.132 per share. The ex-dividend date of this dividend was Monday, October 2nd. This represents a $0.53 annualized dividend and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio is currently 27.32%.
TRADEMARK VIOLATION NOTICE: This news story was first published by Week Herald and is the property of of Week Herald. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://weekherald.com/2017/11/15/calamos-wealth-management-llc-acquires-shares-of-9933-agilent-technologies-inc-a.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.